understanding fda's new intended use rule and its implications
Published 2 years ago • 410 plays • Length 35:24Download video MP4
Download video MP3
Similar videos
-
1:10:44
demystifying fda's human factors guidance
-
48:19
fda's 510(k) modernization: what if anything has changed? is changing? will change?
-
48:41
computer software assurance (csa): understanding the fda’s new draft guidance
-
47:42
how to make sure fda will accept your extractable and leachable (e&l) testing study
-
59:05
understanding the investigational device exemption (ide) process
-
1:24:26
qsr to qmsr: the rewrite of 21 cfr part 820 & key considerations for fda compliance
-
55:41
david a. kessler: the end of overeating - taking control of the insatiable american appetite
-
50:59
theranos aftershock – lessons learned & regulatory/investment changes on the horizon
-
1:20:11
preparing your technical documentation under mdr: proven tips & techniques
-
26:54
understanding the udi system for medical devices
-
16:12
what's the difference between intended use, indications for use, and intended purpose?
-
1:30:26
understanding the medical device classification system
-
56:02
demystifying fda’s pre-market final guidance
-
42:21
how the new fda guidance ‘use of international standard iso 10993-1 affects you
-
38:04
finally, fda finalizes udi requirements document
-
33:47
demystifying the de novo process
-
47:00
how to get covid-19 devices to market using fda emergency use authorization (eua) program
-
1:49
navigating the fda 513(g) process - an essential guide
-
1:00:56
design change impact on biocompatibility and documentation
-
1:28:05
beyond design controls 101: following the regulation vs. understanding its intent
-
4:03
structure function claims regulatory guidance, fda regulations everything you should know!
-
39:03
the fda digital health center of excellence and the advancement of digital health technology